Crystal structure of 2-[5-(2-chlorophenyl)tetrazol-1-yloxy]-1-piperidin-1-yl- ethanone, C14H16CIN5O2

Por Liepa A. J., Nearn R. H., Tiekink E. R. T.
Publicado em 2001-04-01

PD-034 Heterogeneity in the first-line treatment of patients with advanced or metastatic gastric cancer in the US

Por Abrams, T., Hess, L., Zhu, Y., Schelman, W., Liepa, A., Fuchs, C.
Publicado no Ann Oncol (2016)

PD-008 Adding ramucirumab to second-line irinotecan, 5-fluorouracil and folinic acid (FOLFIRI) treatment for metastatic colorectal carcinoma (mCRC): resource utilization data from...

Por Kisro, J., Cohn, A., Yoshino, T., Van Cutsem, E., Hegewisch-Becker, S., Kullmann, F., Brück, P., Liepa, A., Yang, L., Nasroulah, F., Tabernero, J.
Publicado no Ann Oncol (2016)

Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated ga...

Por Al-Batran, S.-E., Van Cutsem, E., Oh, S. C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O. N., Kim, T.-Y., Cunningham, D., Rougier, P., Muro, K., Liepa, A. M., Chandrawansa, K., Emig, M., Ohtsu, A., Wilke, H.
Publicado no Ann Oncol (2016)